[HTML][HTML] Systematic review: fluid biomarkers and machine learning methods to improve the diagnosis from mild cognitive impairment to Alzheimer's disease
K Blanco, S Salcidua, P Orellana… - Alzheimer's Research & …, 2023 - Springer
Mild cognitive impairment (MCI) is often considered an early stage of dementia, with
estimated rates of progression to dementia up to 80–90% after approximately 6 years from …
estimated rates of progression to dementia up to 80–90% after approximately 6 years from …
Systematic review: fluid biomarkers and machine learning methods to improve the diagnosis from mild cognitive impairment to Alzheimer's disease
K Blanco, S Salcidua, P Orellana… - … research & therapy, 2023 - pubmed.ncbi.nlm.nih.gov
Mild cognitive impairment (MCI) is often considered an early stage of dementia, with
estimated rates of progression to dementia up to 80-90% after approximately 6 years from …
estimated rates of progression to dementia up to 80-90% after approximately 6 years from …
[HTML][HTML] Systematic review: fluid biomarkers and machine learning methods to improve the diagnosis from mild cognitive impairment to Alzheimer's disease
K Blanco, S Salcidua, P Orellana… - … Research & Therapy, 2023 - ncbi.nlm.nih.gov
Mild cognitive impairment (MCI) is often considered an early stage of dementia, with
estimated rates of progression to dementia up to 80–90% after approximately 6 years from …
estimated rates of progression to dementia up to 80–90% after approximately 6 years from …
[HTML][HTML] Systematic review: fluid biomarkers and machine learning methods to improve the diagnosis from mild cognitive impairment to Alzheimer's disease
K Blanco, S Salcidua, P Orellana… - Alzheimer's …, 2023 - alzres.biomedcentral.com
Mild cognitive impairment (MCI) is often considered an early stage of dementia, with
estimated rates of progression to dementia up to 80–90% after approximately 6 years from …
estimated rates of progression to dementia up to 80–90% after approximately 6 years from …
[PDF][PDF] Systematic review: fluid biomarkers and machine learning methods to improve the diagnosis from mild cognitive impairment to Alzheimer's disease
K Blanco, S Salcidua, P Orellana, T Sauma‑Pérez… - 2023 - researchgate.net
Mild cognitive impairment (MCI) is often considered an early stage of dementia, with
estimated rates of progres‑sion to dementia up to 80–90% after approximately 6 years from …
estimated rates of progres‑sion to dementia up to 80–90% after approximately 6 years from …
Systematic review: fluid biomarkers and machine learning methods to improve the diagnosis from mild cognitive impairment to Alzheimer's disease.
K Blanco, S Salcidua, P Orellana… - … Research & Therapy, 2023 - go.gale.com
Mild cognitive impairment (MCI) is often considered an early stage of dementia, with
estimated rates of progression to dementia up to 80-90% after approximately 6 years from …
estimated rates of progression to dementia up to 80-90% after approximately 6 years from …
Systematic review: fluid biomarkers and machine learning methods to improve the diagnosis from mild cognitive impairment to Alzheimer's disease
K Blanco, S Salcidua, P Orellana… - Alzheimer's …, 2023 - search.proquest.com
Mild cognitive impairment (MCI) is often considered an early stage of dementia, with
estimated rates of progression to dementia up to 80–90% after approximately 6 years from …
estimated rates of progression to dementia up to 80–90% after approximately 6 years from …
Systematic review: fluid biomarkers and machine learning methods to improve the diagnosis from mild cognitive impairment to Alzheimer's disease.
K Blanco, S Salcidua, P Orellana… - Alzheimer's …, 2023 - search.ebscohost.com
Mild cognitive impairment (MCI) is often considered an early stage of dementia, with
estimated rates of progression to dementia up to 80–90% after approximately 6 years from …
estimated rates of progression to dementia up to 80–90% after approximately 6 years from …
Systematic review: fluid biomarkers and machine learning methods to improve the diagnosis from mild cognitive impairment to Alzheimer's disease.
K Blanco, S Salcidua, P Orellana… - … Research & Therapy, 2023 - europepmc.org
Mild cognitive impairment (MCI) is often considered an early stage of dementia, with
estimated rates of progression to dementia up to 80–90% after approximately 6 years from …
estimated rates of progression to dementia up to 80–90% after approximately 6 years from …
Systematic review: fluid biomarkers and machine learning methods to improve the diagnosis from mild cognitive impairment to Alzheimer's disease.
K Blanco, S Salcidua, P Orellana… - … Research & Therapy, 2023 - europepmc.org
Mild cognitive impairment (MCI) is often considered an early stage of dementia, with
estimated rates of progression to dementia up to 80-90% after approximately 6 years from …
estimated rates of progression to dementia up to 80-90% after approximately 6 years from …